{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T19:44:47Z","timestamp":1775159087471,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["APQ-408675\/2018-7"],"award-info":[{"award-number":["APQ-408675\/2018-7"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.molimm.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T06:31:31Z","timestamp":1592807491000},"page":"161-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis"],"prefix":"10.1016","volume":"124","author":[{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela A.G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5136-0557","authenticated-orcid":false,"given":"L\u00edvia M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-0457","authenticated-orcid":false,"given":"Tha\u00eds T.O.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thiago A.R.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel S.","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourena E.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana C.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2020.06.010_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trivac.2015.11.001","article-title":"Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14 kDa Leishmania infantum recombinant polypeptide","volume":"5","author":"Abeijon","year":"2016","journal-title":"Trials Vaccinol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2018.08.004","article-title":"Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides","volume":"103","author":"Agallou","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molimm.2017.12.015","article-title":"VP2 (PTA motif) encoding DNA vaccine confers protection against lethal challenge with infectious pancreatic necrosis virus (IPNV) in trout","volume":"94","author":"Ahmadivand","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2020.06.010_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2016.12.022","article-title":"Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb\/c mice","volume":"82","author":"Amit","year":"2017","journal-title":"Mol. Immunol."},{"issue":"May(5)","key":"10.1016\/j.molimm.2020.06.010_bib0030","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4269\/ajtmh.1991.44.536","article-title":"Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease","volume":"44","author":"Barral","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.molimm.2020.06.010_bib0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","article-title":"Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example","volume":"10","author":"Bogdan","year":"2008","journal-title":"Cell. Microbiol."},{"issue":"November (13)","key":"10.1016\/j.molimm.2020.06.010_bib0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fcimb.2018.00381","article-title":"Cellular markers of active disease and cure in different forms of leishmania infantum-induced disease","volume":"8","author":"Botana","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"issue":"July (8)","key":"10.1016\/j.molimm.2020.06.010_bib0050","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3389\/fimmu.2017.00750","article-title":"Domain of the leishmania (Leishmania) donovani nucleoside hydrolase promotes a Th1 response in Leishmania (Leishmania) infantum cured patients and in asymptomatic individuals living in an endemic area of leishmaniasis","volume":"12","author":"Carrillo","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0055","doi-asserted-by":"crossref","first-page":"e1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"Coelho","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2020.06.010_bib0060","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2020.06.010_bib0065","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2020.06.010_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.micinf.2017.09.011","article-title":"Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis","volume":"20","author":"Das","year":"2018","journal-title":"Microbes Infect."},{"issue":"December (8)","key":"10.1016\/j.molimm.2020.06.010_bib0075","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3389\/fimmu.2017.01763","article-title":"Identification of potential MHC Class-II-restricted epitopes derived from Leishmania donovani antigens by reverse vaccinology and evaluation of their CD4+ T-cell responsiveness against visceral leishmaniasis","volume":"14","author":"Dikhit","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molimm.2016.06.014","article-title":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","volume":"76","author":"Duarte","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"July (1)","key":"10.1016\/j.molimm.2020.06.010_bib0090","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Reed Interleukin 10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"Ghalib","year":"1993","journal-title":"SG. J. Clin. Invest."},{"issue":"June (26)","key":"10.1016\/j.molimm.2020.06.010_bib0095","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"issue":"July(3)","key":"10.1016\/j.molimm.2020.06.010_bib0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molimm.2020.06.010_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185438","article-title":"Field trial of efficacy of the Leish-Tec\u00aevaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates","volume":"12","author":"Grimaldi","year":"2017","journal-title":"PLoS One"},{"issue":"September (9)","key":"10.1016\/j.molimm.2020.06.010_bib0110","article-title":"Field trial of efficacy of the Leish-tec\u00ae vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates","volume":"12","author":"Grimaldi","year":"2017","journal-title":"PLoS One"},{"issue":"July (2)","key":"10.1016\/j.molimm.2020.06.010_bib0115","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.165.2.915","article-title":"Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells","volume":"165","author":"Gurunathan","year":"2000","journal-title":"J. Immunol."},{"issue":"April (26)","key":"10.1016\/j.molimm.2020.06.010_bib0120","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3389\/fimmu.2018.00884","article-title":"Approaches to improve chemically defined synthetic peptide vaccines","volume":"9","author":"Hos","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2020.06.010_bib0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2019.00288","article-title":"Immunogenicity and protective efficacy of T-cell epitopes derived from potential Th1 stimulatory proteins of Leishmania (Leishmania) donovani","volume":"10","author":"Joshi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/pim.12176","article-title":"Studies on cocktails of 31-kDa, 36-kDa and 51-kDa antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis","volume":"37","author":"Kaur","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7555\/JBR.30.20150125","article-title":"Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB\/c mice","volume":"30","author":"Kaur","year":"2016","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.molimm.2020.06.010_bib0145","first-page":"1","article-title":"Immune responses during cutaneous and visceral leishmaniasis","volume":"30","author":"Kedzierski","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.molimm.2020.06.010_bib0150","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.vaccine.2018.03.027","article-title":"Immunotherapeutic potential of Leishmania (Leishmania) donovani Th1 stimulatory proteins against experimental visceral leishmaniasis","volume":"36","author":"Keerti","year":"2018","journal-title":"Vaccine"},{"issue":"2019","key":"10.1016\/j.molimm.2020.06.010_bib0155","article-title":"New insights on the adjuvant properties of the Leishmania infantum eukaryotic initiation factor","author":"Koutsoni","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.molimm.2020.06.010_bib0160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/15672018113106660057","article-title":"New insights into the diagnosis and chemotheraphy for visceral leishmaniasis","volume":"11","author":"Kumar","year":"2014","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.molimm.2020.06.010_bib0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.imbio.2019.05.008","article-title":"A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein","volume":"224","author":"Lage","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.molimm.2020.06.010_bib0170","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2147\/IJN.S141069","article-title":"Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNF\u03b1-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis","volume":"12","author":"Margaroni","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"June(1)","key":"10.1016\/j.molimm.2020.06.010_bib0175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1297-9716-45-69","article-title":"The protective immune response produced in dogs after primary vaccination with the LiESP\/QA-21 vaccine (CaniLeish\u00ae) remains effective against an experimental challenge one year later","volume":"45","author":"Martin","year":"2014","journal-title":"Vet. Res."},{"issue":"June (6)","key":"10.1016\/j.molimm.2020.06.010_bib0180","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fvets.2019.00168","article-title":"Assessment of vaccine-induced immunity against canine visceral leishmaniasis","volume":"4","author":"Moreno","year":"2019","journal-title":"Front. Vet. Sci."},{"issue":"April","key":"10.1016\/j.molimm.2020.06.010_bib0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2020.01.005","article-title":"Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis","volume":"220","author":"Oliveira-da-Silva","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2020.06.010_bib0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","article-title":"Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome","volume":"62","author":"Peruhype-Magalh\u00e3es","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/sji.12557","article-title":"A non-pathogenic recombinant Leishmania expressing lipophosphoglycan 3 against experimental infection with Leishmania infantum","volume":"86","author":"Pirdel","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1631\/jzus.2007.B0153","article-title":"Adjuvant effects of saponins on animal immune responses","volume":"8","author":"Rajput","year":"2007","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.molimm.2020.06.010_bib0205","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","article-title":"Visceral leishmaniasis: an overview of vaccine adjuvants and their applications","volume":"37","author":"Ratnapriya","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.molimm.2020.06.010_bib0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1586\/14760584.2016.1105135","article-title":"Leishmania vaccine development: exploiting the host-vector-parasite interface","volume":"15","author":"Reed","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"April (19)","key":"10.1016\/j.molimm.2020.06.010_bib0215","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","article-title":"Field randomized trial to evaluate the efficacy of the Leish-Tec\u00ae vaccine against canine visceral leishmaniasis in an endemic area of Brazil","volume":"34","author":"Regina-Silva","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2020.06.010_bib0220","first-page":"1","article-title":"An overview on Leishmania vaccines: a narrative reviewarticle","volume":"6","author":"Rezvan","year":"2015","journal-title":"Vet. Res. Forum"},{"key":"10.1016\/j.molimm.2020.06.010_bib0225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2018.12.025","article-title":"Immunogenicity and protective efficacy of a new Leishmaniahypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection","volume":"106","author":"Ribeiro","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2018.00018","article-title":"Lipossomal elongation factor-1\u03b1 triggers effector CD4 and CD8 T cells for induction of long-lasting protective immunity against visceral leishmaniasis","volume":"9","author":"Sabur","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.actatropica.2017.03.008","article-title":"Probing the efficacy of a heterologous Leishmania Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB\/c mice","volume":"171","author":"Santos","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.molimm.2020.06.010_bib0240","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.vaccine.2016.09.016","article-title":"Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant","volume":"34","author":"Schaut","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2020.06.010_bib0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vetpar.2015.07.005","article-title":"Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis","volume":"212","author":"Shahbazi","year":"2015","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molimm.2017.02.008","article-title":"Inflammatory chemokines and their receptors in human visceral leishmaniasis: gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells","volume":"85","author":"Singh","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0255","doi-asserted-by":"crossref","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2020.06.010_bib0260","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"August (4)","key":"10.1016\/j.molimm.2020.06.010_bib0265","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40291-018-0343-y","article-title":"Molecular diagnosis of visceral leishmaniasis","volume":"22","author":"Sundar","year":"2018","journal-title":"Mol. Diagn. Ther."},{"issue":"November(3)","key":"10.1016\/j.molimm.2020.06.010_bib0270","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.exppara.2013.09.008","article-title":"Degree of anemia correlates with increased utilization of heme by Leishmania donovani parasites in visceral leishmaniasis","volume":"135","author":"Thakur","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.molimm.2020.06.010_bib0275","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.imbio.2015.05.014","article-title":"Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice","volume":"220","author":"Thakur","year":"2015","journal-title":"Immunobiology"},{"issue":"February","key":"10.1016\/j.molimm.2020.06.010_bib0280","article-title":"The impact of canine leishmaniosis vaccination with Canileish\u00ae in Leishmania infantum infection seroprevalence studies","volume":"202","author":"Velez","year":"2020","journal-title":"Acta Trop."},{"issue":"June (6)","key":"10.1016\/j.molimm.2020.06.010_bib0285","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.micinf.2017.03.002","article-title":"Bimal Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects","volume":"19","author":"Vijayamahantesh","year":"2017","journal-title":"S. Microbes Infect."},{"key":"10.1016\/j.molimm.2020.06.010_bib0290","series-title":"Leishmaniasis","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.molimm.2020.06.010_bib0295","first-page":"35","article-title":"Bivalent DNA vaccination with genes encoding Leishmania major cysteine proteinases type I and II protects mice against infectious challenge","volume":"2","author":"Zadeh-Vakili","year":"2004","journal-title":"Iran. J. Biotechnol."}],"updated-by":[{"DOI":"10.1016\/j.molimm.2020.09.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589020303886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589020303886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:36:40Z","timestamp":1758980200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589020303886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":59,"alternative-id":["S0161589020303886"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2020.06.010","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}